Learn to navigate the complexities of selecting a CDMO in this upcoming webinar. We’ll delve into the key criteria for choosing a drug development, manufacturing, and commercialization partner, and we’ll demonstrate how to choose a CDMO that can help you cut costs, expedite time-to-market, and supercharge your product’s success. On Thursday, July 13, join Dr. Srinivasan Shanmugam as he guides the audience through the CDMO selection process and arms them with strategies to avoid common pitfalls.
This webinar will focus on the critical considerations when choosing a CDMO for a successful partnership. Selecting the right CDMO is crucial for a sponsor or outsourcing company, as it significantly affects the product’s success, cost, and time to market.
Creating a solid business partnership case for potential CDMOs is vital, as it showcases the company’s strengths, needs, and expectations. It also offers an opportunity to assess the CDMO’s capabilities and expertise, their approach to collaboration and communication and their alignment with the company’s vision and values. By presenting a clear business case, a meaningful dialogue can be facilitated to determine the right fit for an organization.
It is crucial to map out objectives across all departments to clearly define requirements and identify potential gaps or areas for improvement. This approach enables an organization to choose a CDMO that can meet their needs and provide the required services at the expected level of quality. By considering all departments, such as manufacturing, quality control, regulatory affairs and project management, a well-chosen CDMO can support the entire product development and commercialization journey.
Dr. Shanmugan will cover topics such as the CDMO market, outsourcing models, drivers for outsourcing, the outsourcing and CDMO selection process for successful partnerships, and selection criteria. Challenges that arise during the selection process will also be discussed.
If you’re in the process of selecting a CDMO or seeking to refine your current process, this webinar is for you. Register today!
Dr. Srinivasan Shanmugam, Senior Director of Pharmaceutical Sciences, Business Support and New Technologies
Dr. Srinivasan Shanmugam has over 20 years of experience in designing and developing conventional, NDDS/alternate, advanced/modified drug delivery systems and pharmaceutical platform technologies for oral and other routes of administration. His expertise includes stability, solubility/dissolution, permeability and bioavailability enhancement techniques/technologies for challenging drugs, as well as patient-centric solutions focusing on pediatric and geriatric populations to achieve dose convenience, flexibility and precision.
In his current position, Dr. Shanmugam is involved in the development and expansion of Adare’s pharmaceutical technology portfolio and supports product development, co-development and tech transfer opportunities. He holds a PhD and a BS in pharmacy. Dr. Shanmugam has published numerous research articles, holds multiple patents and serves as a reviewer and editorial member for various prestigious journals. His recent work focuses on product development solutions for special patient populations, such as pediatric and geriatric populations.
Who Should Attend?
- Anyone looking for a CDMO partnership
- Anyone involved in pharma outsourcing
- Outsourcing decision makers
- Procurement professionals
- External Manufacturing Directors/Managers
- CMC Directors & Managers
- Formulation Directors & Managers
What You Will Learn
Attendees will be introduced to:
- Outsourcing and CDMO models
- Drivers for outsourcing
- CDMO selection criteria & common pitfalls
- Establishing a successful partnership with your CDMO
Adare Pharma Solutions
Adare Pharma Solutions is a global technology-driven CDMO providing end-to-end integrated services, from product development through commercial manufacturing and packaging, with small molecule expertise focusing on oral dosage forms. Our specialized technology platforms provide taste masking, controlled release, solubility enhancement, and patient-centric dosing solutions. We have developed and manufactured more than 65 products sold by customers worldwide.
We have the expertise and proven track record to guide projects from clinical research stages through optimization, validation, and approval. We operate seven facilities in the US and Europe, equipped to facilitate efficient drug product development and manufacturing, maintaining excellent environmental conditions compliant with US and EU cGMP regulations.
Adare has dedicated high potency GMP manufacturing and development areas. Our in-house regulatory and quality teams have a proven global track record, assuring our clients that products we manufacture are provided with the highest relevant standards for patient care.